MEDIROM Healthcare Technologies Inc. (MRM)
NASDAQ: MRM · Real-Time Price · USD
0.5600
+0.0100 (1.82%)
Oct 7, 2026, 10:28 AM EDT - Market open

MRM Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4155282230
Market Cap Growth
-72.68%201.38%-81.79%26.83%-25.49%-48.98%
Enterprise Value
314426504249
Last Close Price
0.551.941.035.724.516.05

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
12.9542.885.3834.1119.49-
PS Ratio
0.083.980.100.580.420.63
PB Ratio
2.581.800.8118.23-48.91-16.33

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.5611.420.501.030.791.04
EV/EBITDA Ratio
30.19-14.06-19.54-
EV/EBIT Ratio
-111.38868.97-56.62-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
7.861.754.0116.90-54.42-13.40
Debt / EBITDA Ratio
3.45-3.094.322.674.62
Net Debt / Equity Ratio
7.801.733.6716.40-44.21-11.59
Net Debt / EBITDA Ratio
26.06-12.31-25.499.34-8.98
Net Debt / FCF Ratio
-4.02--2.58-4.61-3.26-3.70
Asset Turnover
1.170.111.111.001.110.94
Inventory Turnover
36.06-41.5141.4076.07299.67
Quick Ratio
0.140.390.560.380.530.39
Current Ratio
0.241.750.650.490.650.43
Return on Equity (ROE)
53.19%4.29%22.96%146.95%--700.38%
Return on Assets (ROA)
-1.78%0.72%0.04%-3.60%0.97%-4.31%
Return on Invested Capital (ROIC)
-4.49%1.50%0.11%-11.41%2.84%-19.11%
Return on Capital Employed (ROCE)
-6.50%2.90%0.10%-11.90%3.10%-15.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
6.57%2.33%18.60%2.93%5.13%-29.12%
FCF Yield
-143.28%--175.45%-19.50%-27.77%-19.19%
Buyback Yield / Dilution
-50.05%--13.26%5.56%-12.16%-21.19%
SEC Filings: 10-K · 10-Q